Nano-Delivered Hydrogen Gas Shows Promise for Liver Fibrosis Treatment
- Authors
- Peiyuan Tian, Jinping Wang, Haohan Yang, Zhenpu Jiang, Jinshuai Xu, Xueli Xu, Nengyi Ni, Teng Liu, Xiao Sun
- Journal
- Materials Today Bio
- Year
- 2026
- DOI
- 10.1016/j.mtbio.2026.103104
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Liver Fibrosis
- Body System
- Hepatic
TL;DR
Scientists found that special medical gases like hydrogen can help heal scarred livers by reducing inflammation and damage, and they're using tiny nano-sized delivery systems to get these gases exactly where they need to go in the body.
Key Finding
Hydrogen and other medical gases show promise for treating liver fibrosis through antioxidant and anti-inflammatory effects that may prevent the cellular processes that cause liver scarring.
Summary
This review examines how medical gases, especially hydrogen, might help treat liver fibrosis (scarring caused by ongoing liver damage). Hydrogen and similar gases work by reducing inflammation, fighting harmful molecules called reactive oxygen species, and preventing the activation of cells that cause scarring. The review focuses on new delivery methods using nanotechnology to get these gases to the liver more effectively.
Practical Takeaway
This is a review article summarizing existing research rather than a new study with experimental results, and it does not appear to include human trials. While the review suggests hydrogen gas therapy may have potential for liver fibrosis, the evidence discussed is preliminary and mostly from laboratory or animal studies. Anyone with liver disease should consult their doctor before considering any new therapeutic approach.
Abstract
Liver fibrosis, a significant global health issue, results from sustained liver injury and is characterized by progressive damage to the liver. Treating liver fibrosis poses considerable challenges due to difficulty in reversal and frequent association with complex, chronic liver injuries. Recently, medical gas therapies have emerged as a promising novel approach for addressing liver fibrosis. The primary gases involved include carbon monoxide (CO), hydrogen (H2), nitric oxide (NO), hydrogen sulfide (H2S), sulfur dioxide (SO2), and oxygen (O2). Several gases exist as endogenous gasotransmitters, thereby inherently capable of participating in known cellular signaling pathways that can be exploited for therapeutic purposes. The principal therapeutic advantages of these gases revolve around the attenuation of key features of liver fibrosis. They exert antioxidant and anti-inflammatory effects, inhibit hepatic stellate cell (HSC) activation and cytokine production, neutralize reactive oxygen species (ROS), and prevent hepatocyte apoptosis. Leveraging on the unique, attractive properties of medical gases, this review examines current scientific findings and investigates the use of advanced delivery modalities, including molecular donors and nanotechnology-based systems, to enhance the specificity of gas therapy for liver fibrosis.